USP-, EP-, BP-, and JP-grade

USP-grade refers to standards set by the United States Pharmacopeia (USP), a non-profit organization defining quality, purity, identity, and strength requirements for drugs, food ingredients, and dietary supplements. Though based in the U.S., USP standards are globally recognized as a benchmark for pharmaceutical quality.

The European Pharmacopoeia (EP), overseen by the European Directorate for the Quality of Medicines & HealthCare (EDQM), sets strict quality standards for pharmaceutical substances, excipients, and dosage forms across Europe. Compliance with EP standards is essential for marketing authorization and trade within the European Economic Area.

The British Pharmacopoeia (BP), published by the British Pharmacopoeia Commission, establishes standards for the quality and purity of medicinal substances, excipients, and formulations. While primarily used in the UK, it’s also recognized internationally to uphold the integrity of medicines.

The Japanese Pharmacopoeia (JP), issued by Japan’s Ministry of Health, Labour and Welfare, defines the quality, purity, and specifications for drugs, excipients, and traditional medicines. It ensures the safety and efficacy of pharmaceuticals within the Japanese market.